These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 29562940)

  • 1. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of bladder tumor fibronectin in patients with bladder tumor: a systematic review with meta-analysis.
    Yang X; Huang H; Zeng Z; Zhao L; Hu P; He D; Tang X; Zeng Z
    Clin Biochem; 2013 Oct; 46(15):1377-82. PubMed ID: 23735602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sathyapalan T; Sahebkar A
    Biomed Res Int; 2021; 2021():5557309. PubMed ID: 33997007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Urine Cytology in Bladder Cancer. A Meta-Analysis.
    Xie Q; Huang Z; Zhu Z; Zheng X; Liu J; Zhang M; Zhang Y
    Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):38-44. PubMed ID: 27363065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
    Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Chen L; Cui Z; Liu Y; Bai Y; Lan F
    Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
    Zhao L; Li J; Xue Z; Wang J
    Clin Transl Oncol; 2024 Jun; 26(6):1497-1507. PubMed ID: 38227115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
    Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
    World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA urothelial carcinoma-associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer.
    Wang Z; Wang X; Zhang D; Yu Y; Cai L; Zhang C
    Tumour Biol; 2017 Jun; 39(6):1010428317709990. PubMed ID: 28639914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis.
    He H; Han C; Hao L; Zang G
    Oncol Lett; 2016 Jul; 12(1):83-88. PubMed ID: 27347104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of the urine UCA1 for diagnosis of bladder cancer: a meta-analysis.
    Cui X; Jing X; Long C; Yi Q; Tian J; Zhu J
    Oncotarget; 2017 May; 8(21):35222-35233. PubMed ID: 28415640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Cheng Y; Deng X; Yang X; Li P; Zhang X; Li P; Tao J; Lu Q; Wang Z
    Onco Targets Ther; 2015; 8():2089-96. PubMed ID: 26316777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
    Arnold SA; Loomans HA; Ketova T; Andl CD; Clark PE; Zijlstra A
    Clin Exp Metastasis; 2016 Jan; 33(1):29-44. PubMed ID: 26456754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.
    Ku JH; Godoy G; Amiel GE; Lerner SP
    BJU Int; 2012 Sep; 110(5):630-6. PubMed ID: 22353238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
    Xia Y; Liu YL; Yang KH; Chen W
    Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.
    Mi Y; Zhao Y; Shi F; Zhang M; Wang C; Liu X
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e11-e19. PubMed ID: 29931834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of urine and blood microRNAs for bladder cancer: a meta-analysis.
    Ye Q; Wang J; Xu D; Liu Y; Zhang D; Ye J; Li H
    Expert Rev Anticancer Ther; 2022 Dec; 22(12):1357-1369. PubMed ID: 36374119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
    Wang J; Gao Y; Wang X; Gao Y; Li L; Zhang J; Zhang L; Che F
    Int J Biol Markers; 2020 Jun; 35(2):40-48. PubMed ID: 32460591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data.
    Xiao S; Wang J; Xiao N
    Int J Biol Markers; 2016 Jul; 31(3):e276-85. PubMed ID: 26954073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.